17/04/2026

Yesterday, LS4FUTURE hosted the TL2 Minisymposium “From in vitro to complex models: exploring tumours/diseases and their microenvironment” at IPO Lisboa, bringing together researchers from across institutions to discuss emerging approaches for studying disease in more physiologically relevant contexts.

As the first of four in-person scientific activities planned for this year, the event created a dynamic space for scientific exchange and cross-institutional dialogue, with a strong focus on how advanced models can better capture the complexity of disease and its interaction with the microenvironment.

The programme featured three inspiring talks:

• Patricia Pérez-Galán (IDIBAPS Hospital Clínic, Spain) presented on patient-derived lymphoma 3D models, highlighting their potential as tools for precision immuno-oncology.
• Sandra Tenreiro (NOVA Medical School) introduced new resources at NMS, including HubP2C and MPS_NOVA, showcasing how New Approach Methodologies (NAMs) are transforming the research landscape.
• Catarina Brito (ITQB NOVA & iBET) explored the development of human-relevant tumour microenvironment models, from 3D co-cultures to ex vivo explants, and their applications in precision oncology.

Beyond the scientific programme, the minisymposium also fostered informal interactions and networking opportunities, allowing participants to connect, exchange ideas, and identify potential areas for collaboration across the LS4FUTURE community.

The event was organized by José Cabeçadas, Hugo Miranda, and Raquel Sá-Leão, whose efforts contributed to a highly engaging and collaborative atmosphere.

This minisymposium marks a strong start to the 2026 LS4FUTURE scientific programme, reinforcing the importance of interdisciplinary approaches and shared platforms to advance research on complex diseases.

Stay tuned for the upcoming LS4FUTURE Thematic Lines initiatives.